Log in

ANCHIANO THERAP/S News Headlines (NASDAQ:ANCN)

$1.38
+0.02 (+1.47 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
$1.33
Now: $1.38
$1.40
50-Day Range
$1.28
MA: $1.39
$1.60
52-Week Range
$1.04
Now: $1.38
$9.25
Volume19,931 shs
Average Volume25,414 shs
Market Capitalization$10.24 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

ANCHIANO THERAP/S (NASDAQ ANCN) News Headlines

Source:
DateHeadline
Head to Head Comparison: ProQR Therapeutics (NASDAQ:PRQR) and ANCHIANO THERAP/S (NASDAQ:ANCN)Head to Head Comparison: ProQR Therapeutics (NASDAQ:PRQR) and ANCHIANO THERAP/S (NASDAQ:ANCN)
www.americanbankingnews.com - February 11 at 5:05 PM
 Analysts Anticipate ANCHIANO THERAP/S (NASDAQ:ANCN) to Announce -$0.13 EPS Analysts Anticipate ANCHIANO THERAP/S (NASDAQ:ANCN) to Announce -$0.13 EPS
www.americanbankingnews.com - February 6 at 10:41 AM
Analysts Expect ANCHIANO THERAP/S (NASDAQ:ANCN) to Announce ($0.13) Earnings Per ShareAnalysts Expect ANCHIANO THERAP/S (NASDAQ:ANCN) to Announce ($0.13) Earnings Per Share
www.americanbankingnews.com - January 30 at 9:54 PM
Anchiano Therapeutics Announces Record Date for 2020 Annual General Meeting of ShareholdersAnchiano Therapeutics Announces Record Date for 2020 Annual General Meeting of Shareholders
finance.yahoo.com - January 17 at 6:32 PM
IPOs Performed Better Than You Think in 2019—With Average Returns of 20%IPOs Performed Better Than You Think in 2019—With Average Returns of 20%
www.barrons.com - December 24 at 12:42 PM
Anchiano Discontinues Phase 2 Codex Study Evaluating Inodiftagene Vixteplasmid in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC); Company Focuses on Advancing Pan-RAS Inhibitor ProgramAnchiano Discontinues Phase 2 Codex Study Evaluating Inodiftagene Vixteplasmid in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC); Company Focuses on Advancing Pan-RAS Inhibitor Program
finance.yahoo.com - November 15 at 9:54 AM
Anchiano Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateAnchiano Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - November 15 at 9:54 AM
Anchiano Therapeutics Chairman Stephen Hoffman Steps Down from BoardAnchiano Therapeutics Chairman Stephen Hoffman Steps Down from Board
finance.yahoo.com - October 24 at 7:00 PM
Anchiano Therapeutics to Present at the Baird 2019 Global Healthcare ConferenceAnchiano Therapeutics to Present at the Baird 2019 Global Healthcare Conference
finance.yahoo.com - September 3 at 11:42 AM
Anchiano Therapeutics Reports Second Quarter 2019 Financial ResultsAnchiano Therapeutics Reports Second Quarter 2019 Financial Results
finance.yahoo.com - August 5 at 8:33 PM
Anchiano Therapeutics Delists Ordinary Shares from the Tel Aviv Stock ExchangeAnchiano Therapeutics Delists Ordinary Shares from the Tel Aviv Stock Exchange
finance.yahoo.com - June 18 at 10:38 AM
Anchiano Therapeutics Announces Appointment of Salar Roshan as Head of Business DevelopmentAnchiano Therapeutics Announces Appointment of Salar Roshan as Head of Business Development
finance.yahoo.com - May 29 at 3:25 PM
Anchiano Therapeutics Reports First Quarter 2019 Financial ResultsAnchiano Therapeutics Reports First Quarter 2019 Financial Results
finance.yahoo.com - May 22 at 3:24 PM
Anchiano Therapeutics to Present at the Oppenheimer 29th Annual Healthcare ConferenceAnchiano Therapeutics to Present at the Oppenheimer 29th Annual Healthcare Conference
finance.yahoo.com - March 15 at 5:14 AM
Anchiano Therapeutics Initiates Process to Voluntarily Delist its Ordinary Shares from the Tel Aviv Stock ExchangeAnchiano Therapeutics Initiates Process to Voluntarily Delist its Ordinary Shares from the Tel Aviv Stock Exchange
finance.yahoo.com - March 14 at 3:15 PM
Anchiano Therapeutics Reports Fourth Quarter and Full Year 2018 Financial ResultsAnchiano Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
finance.yahoo.com - March 12 at 8:16 PM
Anchiano Therapeutics Announces Closing of $30.5 Million Initial Public OfferingAnchiano Therapeutics Announces Closing of $30.5 Million Initial Public Offering
finance.yahoo.com - March 11 at 5:35 PM
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel